Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19331
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/*pharmacokinetics/*therapeutic use,Carcinoma, Non-Small-Cell Lung/*drug therapy/mortality,Cisplatin/administration & dosage/adverse effects/pharmacokinetics,Deoxycytidine/administration & dosage/adverse effects/analogs &,derivatives/pharmacokinetics,Female,Humans,Kaplan-Meier Estimate,Lung Neoplasms/*drug therapy/mortality,Male,Maximum Tolerated Dose,Middle Aged,Salvage Therapy/adverse effects
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19331
ISSN: 0008-543X
Link: http://www.ncbi.nlm.nih.gov/pubmed/18823054
http://onlinelibrary.wiley.com/store/10.1002/cncr.23921/asset/23921_ftp.pdf?v=1&t=h0dexb8u&s=56616e5d680419c1c6fa4918167a9dad39ba04d6
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Froudarakis-2008-Phase 1 trial of lip.pdf146.96 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons